Divergence in the lived experience of people with macular degeneration

Optometry and Vision Science

Volumn 91, Issue 8, 2014, Pages 966-974

  McCloud, Christine ^a   Khadka, Jyoti ^a   Gilhotra, Jagjit Singh ^b,c   Pesudovs, Konrad ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Age related macular degeneration; Anti VEGF; Intravitreal injection; Qualitative; Quality of life

Indexed keywords

DRUG THERAPY; ENDOTHELIAL CELLS; OPHTHALMOLOGY;

AGE-RELATED MACULAR DEGENERATION; ANTI-VEGF; INTRAVITREAL INJECTION; QUALITATIVE; QUALITY OF LIFE;

DISEASES;

ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; ARTICLE; DAILY LIFE ACTIVITY; DRUG ANTAGONISM; EXUDATIVE MACULAR DEGENERATION; FEMALE; GEOGRAPHIC ATROPHY; HUMAN; INFORMATION PROCESSING; INTRAVITREAL DRUG ADMINISTRATION; LOW VISION; MALE; MIDDLE AGED; PATIENT; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; FEMALE; FOCUS GROUPS; GEOGRAPHIC ATROPHY; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; QUALITY OF LIFE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISION, LOW; VISUALLY IMPAIRED PERSONS; WET MACULAR DEGENERATION;

EID: 84905116371     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0000000000000320     Document Type: Article

References (51)

1. Wang JJ, Rochtchina E, Lee AJ, Chia EM, Smith W, Cumming RG, Mitchell P. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. Ophthalmology 2007; 114: 92-8.
2. Guymer RH, Chong EW. Modifiable risk factors for age-related macular degeneration. Med J Aust 2006; 184: 455-8.
3. Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, Klein BE, Smith W, De Jong PT. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004; 111: 1280-7.
4. Pauleikhoff D. Neovascular age-related macular degeneration: natural history and treatment outcomes. Retina 2005; 25: 1065-84.
5. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1419-31.
6. Skaat A, Chetrit A, Belkin M, Kinori M, Kalter-Leibovici O. Time trends in the incidence and causes of blindness in Israel. Am J Ophthalmol 2012; 153: 214-21.e1.
7. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. NEngl J Med 2006; 355: 1432-44.
8. Willis E, Reynolds L, KeleherH.Understanding the AustralianHealth Care System. Sydney, Australia: Churchill Livingstone Elsevier; 2012.
9. Robine JM, Michel JP. Looking forward to a general theory on population aging. J Gerontol A Biol Sci Med Sci 2004; 59: M590-7.
10. Cheung N, Wong TY. Changing trends of blindness: the initial harvest from translational public health and clinical research in ophthalmology. Am J Ophthalmol 2012; 153: 193-5.
11. Geirsdottir A, Jonsson O, Thorisdottir S, Helgadottir G, Jonasson F, Stefansson E, Sigurdsson H. Population-based incidence of exudative age-related macular degeneration and ranibizumab treatment load. Br J Ophthalmol 2012; 96: 444-7.
12. Stevenson MR, Hart PM, Montgomery AM, McCulloch DW, Chakravarthy U. Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer. Br J Ophthalmol 2004; 88: 1125-30.
13. Centre for Eye Research Australia. Clear Insight; The Economic Impact and Cost of Vision Loss in Australia. Melbourne, Australia: Access Economics Pty Limited; 2004.
14. Polder JJ, Bonneux L, Meerding WJ, van der Maas PJ. Age-specific increases in health care costs. Eur J Public Health 2002; 12: 57-62.
15. Richer S, Cho J, Stiles W, Levin M, Wrobel JS, Sinai M, Thomas C. Retinal spectral domain optical coherence tomography in early atrophic age-related macular degeneration (AMD) and a new metric for objective evaluation of the efficacy of ocular nutrition. Nutrients 2012; 4: 1812-27.
16. Rovner BW, Casten RJ, Tasman WS. Effect of depression on vision function in age-related macular degeneration. Arch Ophthalmol 2002; 120: 1041-4.
17. Hassell JB, Lamoureux EL, Keeffe JE. Impact of age related macular degeneration on quality of life. Br J Ophthalmol 2006; 90: 593-6.
18. Shaw ME, Lee A, Stollery R. Ophthalmic Nursing. 4th ed. Oxford, UK: Wiley-Blackwell; 2010.
19. Buch H. Fourteen-year incidence of age-related maculopathy and cause-specific prevalence of visual impairment and blindness in a Caucasian population: the Copenhagen City Eye Study. Acta Ophthalmol Scand 2005; 83: 400-1.
20. Muether PS, Hermann MM, Viebahn U, Kirchhof B, Fauser S. Vascular endothelial growth factor in patients with exudative agerelated macular degeneration treated with ranibizumab. Ophthalmology 2012; 119: 2082-6.
21. Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol 2009; 127: 533-40.
22. Kovach JL, Schwartz SG, Flynn HW, Jr, Scott IU. Anti-VEGF treatment strategies for wet AMD. J Ophthalmol 2012; 2012: 786870.
23. Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010. Am J Ophthalmol 2012; 153: 209-13.e2.
24. Bennion AE, Shaw RL, Gibson JM. What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research. Soc Sci Med 2012; 75: 976-85.
25. Feely M, Vetere A, Myers LB. A qualitative analysis of reading rehabilitation of persons with age-related macular degeneration. J Vis Impair Blind 2007; 101: 44-9.
26. Mogk M. The difference that age makes: cultural factors that shape older adults' responses to age-related macular degeneration. J Vis Impair Blind 2008; 102: 581-90.
27. Stanford P, Waterman H, Russell WB, Harper RA. Psychosocial adjustment in age related macular degeneration. Br J Vis Impair 2009; 27: 129-46.
28. Holloway I, Wheeler S. Qualitative Research in Nursing and Helath Care. 3rd ed. Chichester, West Sussex, UK: Wiley-Blackwell; 2009.
29. Polit DF, Beck CT. Nursing Research: Principles and Methods. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
30. Schneider Z, Whitehead D, LoBiondo-Wood G, Haber J. Nursing and Midwifery Research: Methods and Appraisal for Evidence-Based Practice. 4th ed. Sydney, Australia: Mosby-Elsevier; 2013.
31. Polit DF, Beck CT. Nursing Research: Generating and Assessing Evidence for Nursing Practice. 9th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2012.
32. Thetford C, Hodge S, Harding S, Taylor S, Knox PC. Living with age-related macular degeneration treatment: patient experiences of being treated with ranibizumab (Lucentis\) intravitreal injections. Br J Vis Impair 2013; 31: 89-101.
33. Owsley C, McGwin G, Scilley K, Dreer LE, Bray CR, Mason JO. Focus groups with persons who have age-related macular degeneration: emotional issues. Rehabil Psychol 2006; 51: 23-9.
34. Slakter JS, Stur M. Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment. Surv Ophthalmol 2005; 50: 263-73.
35. Burton AE, Shaw R, Gibson J. Experiences of patients with agerelated macular degeneration receiving anti-vascular endothelial growth factor therapy: a qualitative study. Br J Vis Impair 2013; 31: 178-88.
36. Wahl HW, Becker S, Burmedi D, Schilling O. The role of primary and secondary control in adaptation to age-related vision loss: a study of older adults with macular degeneration. Psychol Aging 2004; 19: 235-9.
37. Moore LW, Miller M. Driving strategies used by older adults with macular degeneration: assessing the risks.ApplNursRes 2005; 18: 110-6.
38. Mogk M. The difference that age makes: cultural factors that shape older adults' responses to age-related macular degeneration. J Vis Impair Blind 2008; 102: 581-90.
39. Wong EYH, Guymer RH, Hassell JB, Keeffe JE. The experience of age-relatedmacular degeneration. J Vis Impair Blind 2004; 98: 629-40.
40. Liu CJ, Brost MA, Horton VE, Kenyon SB, Mears KE. Occupational therapy interventions to improve performance of daily activities at home for older adults with low vision: a systematic review. Am J Occup Ther 2013; 67: 279-87.
41. Coco-Martin MB, Cuadrado-Asensio R, Lopez-Miguel A, Mayo- Iscar A, Maldonado MJ, Pastor JC. Design and evaluation of a customized reading rehabilitation program for patients with agerelated macular degeneration. Ophthalmology 2013; 120: 151-9.
42. Nguyen NX, Weismann M, Trauzettel-Klosinski S. Improvement of reading speed after providing of low vision aids in patients with agerelated macular degeneration. Acta Ophthalmol 2009; 87: 849-53.
43. Lee L, Packer TL, Tang SH, Girdler S. Self-management education programs for age-related macular degeneration: a systematic review. Australas J Ageing 2008; 27: 170-6.
44. Routasalo PE, Tilvis RS, Kautiainen H, Pitkala KH. Effects of psychosocial group rehabilitation on social functioning, loneliness and well-being of lonely, older people: randomized controlled trial. J Adv Nurs 2009; 65: 297-305.
45. Saldana J. Fundamentals of Qualitative Research: Understanding Qualitative Research. New York, NY: Oxford University Press; 2011.
46. Morse JM. Qualitative Health Research : Creating a New Discipline. Walnut Creek, CA: Left Coast Press; 2012.
47. Pesudovs K. Item banking: a generational change in patient-reported outcome measurement. Optom Vis Sci 2010; 87: 285-93.
48. Khadka J, McAlinden C, Craig JE, Fenwick EK, Lamoureux EL, Pesudovs K. Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters. J Glaucoma 2013; April 2, 2013; epub ahead of print: doi: 10.1097/IJG.0b013e318287ac11.
49. Fenwick EK, Pesudovs K, Khadka J, Rees G, Wong TY, Lamoureux EL. Evaluation of item candidates for a diabetic retinopathy quality of life item bank. Qual Life Res 2013; 22: 1851-8.
50. Fenwick EK, Pesudovs K, Khadka J, Dirani M, Rees G, Wong TY, Lamoureux EL. The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project. Qual Life Res 2012; 21: 1771-82.
51. Khadka J, McAlinden C, Pesudovs K. Quality assessment of ophthalmic questionnaires: review and recommendations. Optom Vis Sci 2013; 90: 720-44.